logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10112911 B1

PDFFull Text
Date of Patent:
Oct. 30, 2018

Filed:

Jun. 28, 2013

Substituted cyanoguanidines as oral anti-virals

Applicant:

Abbvie Inc, North Chicago, IL (US);

Inventors:

Artour Gomtsian, Vernon Hills, IL (US);

Tatyana Dekhtyar, Libertyville, IL (US);

Kristine E. Frank, Grayslake, IL (US);

Michael M. Friedman, Brookline, MA (US);

Nathan Josephsohn, Boston, MA (US);

M-Akhteruzzaman Molla, Gurnee, IL (US);

Anil Vasudevan, Union Grove, WI (US);

Iok Chan Ng, Arlington Heights, IL (US);

Mikhail Chafeev, Toronto, CA;

Assignee:

ABBVIE INC., North Chicago, IL (US);

Attorney:

Neal, Gerber & Eisenberg LLP

Primary Examiner:

Douglas M Willis

Int. Cl.
CPC ...
A61K 31/495 (2006.01); A61K 31/497 (2006.01); C07D 241/04 (2006.01); C07D 241/26 (2006.01); A61K 31/498 (2006.01); C07D 413/04 (2006.01); A61K 31/496 (2006.01); A61K 31/517 (2006.01); C07D 487/04 (2006.01); A61K 31/519 (2006.01); C07D 405/14 (2006.01); C07D 403/14 (2006.01); A61K 31/499 (2006.01); A61K 31/5377 (2006.01); A61K 31/4985 (2006.01); C07D 401/14 (2006.01); C07D 401/04 (2006.01); C07D 403/04 (2006.01); C07D 405/04 (2006.01); C07D 417/04 (2006.01); C07D 241/44 (2006.01); C07D 471/04 (2006.01); C07D 317/66 (2006.01); C07D 231/40 (2006.01); C07C 335/30 (2006.01);
U.S. Cl.
CPC ...
C07D 241/26 (2013.01); A61K 31/496 (2013.01); A61K 31/497 (2013.01); A61K 31/498 (2013.01); A61K 31/499 (2013.01); A61K 31/4985 (2013.01); A61K 31/517 (2013.01); A61K 31/519 (2013.01); A61K 31/5377 (2013.01); C07C 335/30 (2013.01); C07D 231/40 (2013.01); C07D 241/44 (2013.01); C07D 317/66 (2013.01); C07D 401/04 (2013.01); C07D 401/14 (2013.01); C07D 403/04 (2013.01); C07D 403/14 (2013.01); C07D 405/04 (2013.01); C07D 405/14 (2013.01); C07D 413/04 (2013.01); C07D 417/04 (2013.01); C07D 471/04 (2013.01); C07D 487/04 (2013.01);
Abstract

This disclosure relates to: (a) compounds and salts of formula (I), formula (II), formula (III), and formula (IV), that, inter alia, inhibit RSV infection and/or replication; (b) intermediates useful for the preparation of such compounds and salts; (c) compositions comprising such compounds and salts; (d) methods for preparing such intermediates, compounds, salts, and compositions; (e) methods of use of such compounds, salts, and compositions; and (f) kits comprising such compounds, salts, and compositions.

Find Patent Forward Citations

Loading…